Skip to content

COSMOS HEALTH INC.: 10-Q filed 2013-05-13

What COSMOS HEALTH INC. reported in its quarterly report filed 2013-05-13 (fiscal Q3 2013): 14 published measures, 49 facts as tagged in accession 0001477932-13-002318.

This filing

Form
10-Q (quarterly report)
Filed
2013-05-13
Fiscal period
fiscal Q3 2013
Accession
0001477932-13-002318 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All COSMOS HEALTH INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2013-04-306,143USD
At 2012-07-3140USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2013-04-30300,700USD
At 2012-07-31213,162USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2013-04-30-294,557USD
At 2012-07-31-213,122USD
At 2011-07-31-4,762USD
At 2010-07-31-17,481USD
At 2009-07-31-4,600USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2013-04-306,143USD
At 2012-07-3140USD
At 2012-04-3035USD
At 2011-07-3115,238USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2013-02-01 to 2013-04-30-58,043USD89
2012-08-01 to 2013-04-30-300,703USD273
2009-07-21 to 2013-04-30-4,593,366USD1380
2011-08-01 to 2012-07-31-330,589USD366
2012-02-01 to 2012-04-30-54,564USD90
2011-08-01 to 2012-04-30-270,863USD274
2010-08-01 to 2011-07-31-169,245USD365
2009-08-01 to 2010-07-31-3,788,229USD365
2009-07-21 to 2009-07-31-4,600USD11

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-08-01 to 2013-04-30-73,631USD273
2009-07-21 to 2013-04-30-296,586USD1380
2011-08-01 to 2012-04-30-54,126USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-08-01 to 2013-04-3079,734USD273
2009-07-21 to 2013-04-30302,729USD1380
2011-08-01 to 2012-04-3038,923USD274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2012-08-01 to 2013-04-30237,400USD273

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-08-01 to 2013-04-30113,351USD273
2009-07-21 to 2013-04-303,984,647USD1380
2011-08-01 to 2012-04-3087,900USD274

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2013-02-01 to 2013-04-30-58,043USD89
2012-08-01 to 2013-04-30-300,703USD273
2009-07-21 to 2013-04-30-4,593,366USD1380
2012-02-01 to 2012-04-30-54,564USD90
2011-08-01 to 2012-04-30-270,863USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2013-04-3025,305,532shares
At 2012-07-3124,709,282shares

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2013-02-01 to 2013-04-3056,023USD89
2012-08-01 to 2013-04-30294,785USD273
2009-07-21 to 2013-04-304,581,984USD1380
2012-02-01 to 2012-04-3052,825USD90
2011-08-01 to 2012-04-30267,404USD274

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2012-08-01 to 2013-04-300USD273
2011-08-01 to 2012-07-310USD366

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2012-08-01 to 2013-04-30100,000USD273
2009-07-21 to 2013-04-30302,729USD1380
2011-08-01 to 2012-04-3024,100USD274

Inspect the source

Entity
COSMOS HEALTH INC. / CIK 0001474167
Captured
2026-09-20T09:07:57.368Z
SEC response SHA-256
f91884dcfc5ed49a155a49d6e8abdd1a5d8586cbb0334ac226e4561bd32d019e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001474167.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))